Search research articles
Contact Us
Filters
Showing results (41-50 of 149) with videos related to
Page
of 15
Sort By:
The Journal of Clinical Psychiatry
|
June 18, 2005
Dual reuptake inhibitors incur lower rates of tachyphylaxis than selective serotonin reuptake inhibitors: a retrospective study
Michael A Posternak, Mark Zimmerman
Archives Internationales De Pharmacodynamie Et De Therapie
|
August 1, 1970
[Influence of temperature on the differential anesthesia of sensory A alpha and motor fibers of the frog]
J C Aubry, J M Posternak
Physical Review. B, Condensed Matter
|
October 15, 1994
Ab initio study of piezoelectricity and spontaneous polarization in ZnO
Dal Corso A, Posternak, Resta, et al.
The American Journal on Addictions
|
March 28, 2001
Assessing the risks and benefits of benzodiazepines for anxiety disorders in patients with a history of substance abuse or dependence
M A Posternak, T I Mueller
Annales De Dermatologie Et De Syphiligraphie
|
January 1, 1976
[Fibroepithelial tumors of Pinkus with extra-dorsal, lumbar and sacral localizations -31 cases]
M F Posternak, M J Civatte
Dermatologica
|
January 1, 1977
[Demonstrations]
P Laugier, F Posternak, M Harms
Hospital & Community Psychiatry
|
July 1, 1980
Educating deinstitutionalized patients about fiscal realities
A Mueller, B Posternak, E Handler
International Clinical Psychopharmacology
|
April 23, 2004
A review of studies of the Montgomery-Asberg Depression Rating Scale in controls: implications for the definition of remission in treatment studies of depression
Mark Zimmerman, Iwona Chelminski, Michael Posternak
The Journal of Nervous and Mental Disease
|
September 7, 2004
A review of studies of the Hamilton depression rating scale in healthy controls: implications for the definition of remission in treatment studies of depression
Mark Zimmerman, Iwona Chelminski, Michael Posternak
Journal of Affective Disorders
|
April 20, 2004
An illustration of how a self-report diagnostic screening scale could improve the internal validity of antidepressant efficacy trials
Mark Zimmerman, Iwona Chelminski, Michael Posternak
Page
of 15
Search research articles
Search
Showing results (41-50 of 149) with videos related to
Sort By:
Page
of 15
The Journal of Clinical Psychiatry
|
June 18, 2005
Dual reuptake inhibitors incur lower rates of tachyphylaxis than selective serotonin reuptake inhibitors: a retrospective study
Michael A Posternak, Mark Zimmerman
Archives Internationales De Pharmacodynamie Et De Therapie
|
August 1, 1970
[Influence of temperature on the differential anesthesia of sensory A alpha and motor fibers of the frog]
J C Aubry, J M Posternak
Physical Review. B, Condensed Matter
|
October 15, 1994
Ab initio study of piezoelectricity and spontaneous polarization in ZnO
Dal Corso A, Posternak, Resta, et al.
The American Journal on Addictions
|
March 28, 2001
Assessing the risks and benefits of benzodiazepines for anxiety disorders in patients with a history of substance abuse or dependence
M A Posternak, T I Mueller
Annales De Dermatologie Et De Syphiligraphie
|
January 1, 1976
[Fibroepithelial tumors of Pinkus with extra-dorsal, lumbar and sacral localizations -31 cases]
M F Posternak, M J Civatte
Dermatologica
|
January 1, 1977
[Demonstrations]
P Laugier, F Posternak, M Harms
Hospital & Community Psychiatry
|
July 1, 1980
Educating deinstitutionalized patients about fiscal realities
A Mueller, B Posternak, E Handler
International Clinical Psychopharmacology
|
April 23, 2004
A review of studies of the Montgomery-Asberg Depression Rating Scale in controls: implications for the definition of remission in treatment studies of depression
Mark Zimmerman, Iwona Chelminski, Michael Posternak
The Journal of Nervous and Mental Disease
|
September 7, 2004
A review of studies of the Hamilton depression rating scale in healthy controls: implications for the definition of remission in treatment studies of depression
Mark Zimmerman, Iwona Chelminski, Michael Posternak
Journal of Affective Disorders
|
April 20, 2004
An illustration of how a self-report diagnostic screening scale could improve the internal validity of antidepressant efficacy trials
Mark Zimmerman, Iwona Chelminski, Michael Posternak
Page
of 15